|
1
|
Collins Y, Chouchani ET, James AM, Menger
KE, Cochemé HM and Murphy MP: Mitochondrial redox signalling at a
glance. J Cell Sci. 125:801–806. 2012.PubMed/NCBI
|
|
2
|
Forkink M, Basit F, Teixeira J, Swarts HG,
Koopman WJH and Willems PHGM: Complex I and complex III inhibition
specifically increase cytosolic hydrogen peroxide levels without
inducing oxidative stress in HEK293 cells. Redox Biol. 6:607–616.
2015.PubMed/NCBI
|
|
3
|
Zhang YW, Zheng Y, Wang JZ, Lu XX, Wang Z,
Chen LB, Guan XX and Tong JD: Integrated analysis of DNA
methylation and mRNA expression profiling reveals candidate genes
associated with cisplatin resistance in non-small cell lung cancer.
Epigenetics. 9:896–909. 2014.PubMed/NCBI
|
|
4
|
Wan M, Bennett BD, Pittman GS, Campbell
MR, Reynolds LM, Porter DK, Crowl CL, Wang X, Su D, Englert NA, et
al: Identification of smoking-associated differentially methylated
regions using reduced representation bisulfite sequencing and cell
type-specific enhancer activation and gene expression. Environ
Health Perspect. 126:0470152018.PubMed/NCBI
|
|
5
|
Deng F, Yang ZF and Sun CQ: The role of
Notch1 genes in lung cancer A594 cells and the impact on
chemosensitivity. Eur Rev Med Pharmacol Sci. 21:2659–2664.
2017.PubMed/NCBI
|
|
6
|
Park W: MAPK inhibitors, particularly the
JNK inhibitor, increase cell death effects in
H2O2-treated lung cancer cells via increased
superoxide anion and glutathione depletion. Oncol Rep. 39:860–870.
2018.PubMed/NCBI
|
|
7
|
Sun C, Jin W and Shi H: Oligomeric
proanthocyanidins protects A549 cells against
H2O2-induced oxidative stress via the
Nrf2-ARE pathway. Int J Mol Med. 39:1548–1554. 2017.PubMed/NCBI
|
|
8
|
Bird A: DNA methylation patterns and
epigenetic memory. Genes Dev. 16:6–21. 2002.PubMed/NCBI
|
|
9
|
Rauscher GH, Kresovich JK, Poulin M, Yan
L, Macias V, Mahmoud AM, Al-Alem U, Kajdacsy-Balla A, Wiley EL,
Tonetti D and Ehrlich M: Exploring DNA methylation changes in
promoter, intragenic, and intergenic regions as early and late
events in breast cancer formation. BMC Cancer.
15:8162015.PubMed/NCBI
|
|
10
|
Chen X, Liu L, Mims J, Punska EC, Williams
KE, Zhao W, Arcaro KF, Tsang AW, Zhou X and Furdui CM: Analysis of
DNA methylation and gene expression in radiation-resistant head and
neck tumors. Epigenetics. 10:545–561. 2015.PubMed/NCBI
|
|
11
|
Cheah SY, Lawford BR, Young RM, Morris CP
and Voisey J: mRNA Expression and DNA methylation analysis of
serotonin receptor 2A (HTR2A) in the human schizophrenic brain.
Genes (Basel). 8:142017.
|
|
12
|
Diederich M, Hansmann T, Heinzmann J,
Barg-Kues B, Herrmann D, Aldag P, Baulain U, Reinhard R, Kues W,
Weissgerber C, et al: DNA methylation and mRNA expression profiles
in bovine oocytes derived from prepubertal and adult donors.
Reproduction. 144:319–330. 2012.PubMed/NCBI
|
|
13
|
Anglim PP, Galler JS, Koss MN, Hagen JA,
Turla S, Campan M, Weisenberger DJ, Laird PW, Siegmund KD and
Laird-Offringa IA: Identification of a panel of sensitive and
specific DNA methylation markers for squamous cell lung cancer. Mol
Cancer. 7:622008.PubMed/NCBI
|
|
14
|
Del Real A, Pérez-Campo FM, Fernández AF,
Sañudo C, Ibarbia CG, Pérez-Núñez MI, Criekinge WV, Braspenning M,
Alonso MA, et al: Differential analysis of genome-wide methylation
and gene expression in mesenchymal stem cells of patients with
fractures and osteoarthritis. Epigenetics. 12:113–122.
2017.PubMed/NCBI
|
|
15
|
Kernaleguen M, Daviaud C, Shen Y, Bonnet
E, Renault V, Deleuze JF, Mauger F and Tost J: Whole-genome
bisulfite sequencing for the analysis of genome-wide dnamethylation
and hydroxymethylation patterns at single-nucleotide resolution.
Methods Mol Biol. 1767:311–349. 2018.PubMed/NCBI
|
|
16
|
Riesewijk A, Martín J, van Os R,
Horcajadas JA, Polman J, Pellicer A, Mosselman S and Simón C: Gene
expression profiling of human endometrial receptivity on days LH+2
versus LH+7 by microarray technology. Mol Hum Reprod. 9:253–264.
2003.PubMed/NCBI
|
|
17
|
Guo K, Elzinga S, Eid S, Figueroa-Romero
C, Hinder LM, Pacut C, Feldman EL and Hur J: Genome-wide DNA
methylation profiling of human diabetic peripheral neuropathy in
subjects with type 2 diabetes mellitus. Epigenetics. 14:766–779.
2019.PubMed/NCBI
|
|
18
|
Navarro A, Yin P, Monsivais D, Lin SM, Du
P, Wei JJ and Bulun SE: Genome-Wide DNA methylation indicates
silencing of tumor suppressor genes in uterine leiomyoma. PLoS One.
7:e332842012.PubMed/NCBI
|
|
19
|
Li P, Shi J, He Q, Hu Q, Wang YY, Zhang
LJ, Chan WT and Chen WX: Streptococcus pneumoniae induces autophagy
through the Inhibition of the PI3K-I/Akt/mTOR Pathway and ROS
Hypergeneration in A549 Cells. PLoS One. 10:e01227532015.PubMed/NCBI
|
|
20
|
Daugaard I, Dominguez D, Kjeldsen TE,
Kristensen LS, Hager H, Wojdacz TK and Hansen LL: Identification
and validation of candidate epigenetic biomarkers in lung
adenocarcinoma. Sci Rep. 6:358072016.PubMed/NCBI
|
|
21
|
Ponsuksili S, Trakooljul N, Basavaraj S,
Hadlich F, Murani E and Wimmers K: Epigenome-wide skeletal muscle
DNA methylation profiles at the background of distinct metabolic
types and ryanodine receptor variation in pigs. BMC Genomics.
20:4922019.PubMed/NCBI
|
|
22
|
Srinivas V, Kitagawa M, Wong J, Liao PJ
and Lee SH: The Tumor suppressor Cdkn3 is required for maintaining
the proper number of centrosomes by regulating the centrosomal
stability of Mps1. Cell Rep. 13:1569–1577. 2015.PubMed/NCBI
|
|
23
|
Zang X, Chen M, Zhou Y, Xiao G, Xie Y and
Wang X: Identifying CDKN3 gene expression as a prognostic biomarker
in lung adenocarcinoma via meta-analysis. Cancer Inform. 14 (Suppl
2):S183–S191. 2015.
|
|
24
|
Fan C, Chen L, Huang Q, Shen T, Welsh EA,
Teer JK, Cai J, Cress WD and Wu J: Overexpression of major CDKN3
transcripts is associated with poor survival in lung
adenocarcinoma. Br J Cancer. 113:1735–1743. 2015.PubMed/NCBI
|
|
25
|
Imai K, Hirata S, Irie A, Senju S, Ikuta
Y, Yokomine K, Harao M, Inoue M, Tomita Y, Tsunoda T, et al:
Identification of HLA-A2-restricted CTL epitopes of a novel
Tumour-associated antigen, KIF20A, overexpressed in pancreatic
cancer. Br J Cancer. 104:300–307. 2011.PubMed/NCBI
|
|
26
|
Yan GR, Zou FY, Dang BL, Zhang Y, Yu G,
Liu X and He QY: Genistein-induced mitotic arrest of gastric cancer
cells by downregulating KIF20A, a proteomics study. Proteomics.
12:2391–2399. 2012.PubMed/NCBI
|
|
27
|
Saito K, Ohta S, Kawakami Y, Yoshida K and
Toda M: Functional analysis of KIF20A, a potential
immunotherapeutic target for glioma. J Neurooncol. 132:63–74.
2017.PubMed/NCBI
|
|
28
|
Ni M, Liu X, Wu J, Zhang D, Tian J, Wang
T, Liu S, Meng Z, Wang K, Duan X, et al: Identification of
candidate biomarkers correlated with the pathogenesis and prognosis
of non-small cell lung cancer via integrated bioinformatics
analysis. Front Genet. 9:4692018.PubMed/NCBI
|
|
29
|
Gasnereau I, Boissan M, Margall-Ducos G,
Couchy G, Wendum D, Bourgain-Guglielmetti F, Desdouets C, Lacombe
ML, Zucman-Rossi J and Sobczak-Thépot J: KIF20A mRNA and its
product MKlp2 Are increased during hepatocyte proliferation and
hepatocarcinogenesis. Am J Pathol. 180:131–140. 2012.PubMed/NCBI
|
|
30
|
Yang H, Chang F, You C, Cui J, Zhu G, Wang
L, Zheng Y, Qi J and Ma H: Whole-genome DNA methylation patterns
and complex associations with gene structure and expression during
flower development in Arabidopsis. Plant J. 81:268–281.
2014.PubMed/NCBI
|
|
31
|
Xie H, Chen P, Huang HW, Liu LP and Zhao
F: Reactive oxygen species downregulate ARID1A expression via its
promoter methylation during the pathogenesis of endometriosis. Eur
Rev Med Pharmacol Sci. 21:4509–4515. 2017.PubMed/NCBI
|
|
32
|
Wang YW, Ma X, Zhang YA, Wang MJ, Yatabe
Y, Lam S, Girard L, Chen JY and Gazdar AF: ITPKA gene body
methylation regulates gene expression and serves as an early
diagnostic marker in lung and other cancers. J Thorac Oncol.
11:1469–1481. 2016.PubMed/NCBI
|
